- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Malignant Testicular Germ Cell Tumor
Total 10143 results
-
Assiut UniversityCompletedOvarian Neoplasms | Germ Cell Tumors | ImmunohistochemistryEgypt
-
National Cancer Institute (NCI)Children's Oncology GroupActive, not recruitingRecurrent Hodgkin Lymphoma | Refractory Hodgkin Lymphoma | Rhabdoid Tumor | Advanced Malignant Solid Neoplasm | Refractory Malignant Solid Neoplasm | Ann Arbor Stage III Hodgkin Lymphoma | Ann Arbor Stage IV Hodgkin Lymphoma | Recurrent Ependymoma | Recurrent Ewing Sarcoma | Recurrent Hepatoblastoma | Recurrent... and other conditionsUnited States, Puerto Rico
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.RecruitingAdvanced Malignant Perivascular Epithelioid Cell Tumor (PEComa)China
-
Universitaire Ziekenhuizen KU LeuvenUnknownMalignant GliomasBelgium
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Novartis; Beth Israel Deaconess Medical Center; Brigham and Women's HospitalCompletedNeuroendocrine Tumor | Carcinoid Tumor | Pancreatic Neuroendocrine TumorUnited States
-
Children's Cancer and Leukaemia GroupUnknownInfertility | Ovarian Cancer | Sexual Dysfunction | Neurotoxicity | Long-term Effects Secondary to Cancer Therapy in Children | Gastrointestinal Complications | Urinary Complications | Pulmonary Complications | Extragonadal Germ Cell Tumor | Childhood Germ Cell TumorIreland, United Kingdom
-
Centre Hospitalier Universitaire de BesanconUnknownCompliance, Patient | Germ Cell Tumor | Follow-up | Text MessagingFrance
-
Tata Memorial HospitalCompleted
-
University of Colorado, DenverNational Comprehensive Cancer Network; Taiho Oncology, Inc.RecruitingMalignant MelanomaUnited States
-
Quanli GaoNot yet recruiting
-
Inge Marie SvaneTechnical University of DenmarkRecruiting
-
A.J.M. van den EertweghIdera Pharmaceuticals, Inc.Recruiting
-
Uppsala UniversityRecruiting
-
Universitair Ziekenhuis BrusselRecruitingMalignant MelanomaBelgium
-
Immunocore LtdAstraZenecaCompletedMalignant MelanomaUnited States
-
St. Jude Children's Research HospitalSchering-PloughActive, not recruitingMalignant MelanomaUnited States
-
Lokon Pharma ABPrecision Oncology LLCCompletedMalignant MelanomaSweden, United States
-
Immodulon Therapeutics LtdTerminatedMalignant MelanomaUnited Kingdom
-
Beth Israel Deaconess Medical CenterDana-Farber Cancer InstituteCompletedMalignant MelanomaUnited States
-
Linkoeping UniversityKarolinska Institutet; Region Östergötland; Region Stockholm; Kronoberg County... and other collaboratorsCompleted
-
Ludwig Institute for Cancer ResearchTerminated
-
Ludwig Institute for Cancer ResearchCancer Research Institute (CRI)CompletedMalignant MelanomaUnited States
-
Ludwig Institute for Cancer ResearchTerminated
-
4SC AGCompletedMalignant MelanomaGermany, Italy
-
Hoffmann-La RocheCompletedMalignant MelanomaUnited States, Australia, Brazil, Spain, South Africa, Ukraine, Bosnia and Herzegovina
-
Ultimovacs ASAOslo University HospitalActive, not recruiting
-
University of Kansas Medical CenterCompletedMalignant MelanomaUnited States
-
University of BaselUniversity Hospital, Basel, SwitzerlandCompletedMalignant Melanoma
-
CelgenePrologue Research InternationalCompleted
-
Eli Lilly and CompanyCompletedMalignant MelanomaUnited States
-
Milton S. Hershey Medical CenterCompletedMalignant MelanomaUnited States
-
Skin Analytics LimitedCompleted
-
University of ArizonaTerminatedMalignant MelanomaUnited States
-
Henan Cancer HospitalJiangsu HengRui Medicine Co., Ltd.UnknownMalignant MelanomaChina
-
Hoffmann-La RocheCompletedMalignant MelanomaCanada, Spain, United Kingdom, Hungary, Australia, Austria, Belgium, Ecuador, Estonia, Finland, Ireland, Italy, Korea, Republic of, Mexico, Netherlands, Portugal, Slovenia, Sweden, Turkey, Brazil, India, Germany, Bosnia and Herzegovina and more
-
Bristol-Myers SquibbNo longer availableMalignant MelanomaUnited States, Canada
-
Hoffmann-La RocheCompleted
-
University of California, DavisCompletedMelanoma | Malignant MelanomaUnited States
-
AstraZenecaCompletedMelanoma | Malignant MelanomaUnited Kingdom, Netherlands
-
University Hospital TuebingenGerman Research FoundationCompleted
-
AstraZenecaCompleted
-
Cytos Biotechnology AGCompletedMalignant MelanomaSwitzerland
-
Bristol-Myers SquibbCompletedMalignant MelanomaUnited States
-
SentoClone ABUnknownMalignant MelanomaSweden
-
Royal Marsden NHS Foundation TrustUnknown
-
University Hospital TuebingenCompletedMalignant MelanomaGermany
-
Cytos Biotechnology AGCompletedMalignant MelanomaSwitzerland
-
Yusuf MendaNational Cancer Institute (NCI); Holden Comprehensive Cancer Center; Perspective...Enrolling by invitationNeuroendocrine Tumor Grade 2 | Neuroendocrine Tumor Grade 1United States
-
Dr. Ronnie ShapiraNot yet recruitingMetastatic Melanoma | Malignant Melanoma | Immunotherapy | Malignant Melanoma Stage IV | BRAF V600E